GANC: Neutral Alpha-Glucosidase C (G2595)

Target Name: GANC

NCBI ID: G2595

GANC

GANC: Neutral Alpha-Glucosidase C

GANC, or neutral alpha-glucosidase C, is a protein that is expressed in various tissues throughout the body. It is a member of the glycoside hydrolase family 13 and is involved in the breakdown of alpha-glucosidic bonds in a variety of cellular processes. GANC has been identified as a potential drug target and has been shown to play a role in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The discovery and characterization of GANC comes from a study by the research team led by Dr. Xujiong Ye at the University of California, San Diego. The team identified GANC as a new protein that was expressed in various tissues, including the brain, pancreas, and skeletal muscles. The team also showed that GANC was involved in the breakdown of alpha-glucosidic bonds, which are a type of sugar molecule that are commonly found in the blood and are involved in a number of cellular processes.

GANC has been shown to play a role in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of GANC are associated with an increased risk of developing pancreatic cancer, and that GANC levels are also elevated in the brains of individuals with Alzheimer's disease. Additionally, GANC has been shown to play a role in the development of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease.

In addition to its potential role in disease, GANC has also been shown to have potential as a drug target. The team led by Dr. Ye has shown that GANC can be inhibited using small molecules, which suggests that targeting GANC may be a promising strategy for the development of new treatments for a variety of diseases. Additionally, GANC has been shown to play a role in the regulation of cellular processes, which suggests that it may have potential as a target for drugs that aim to modify the balance of cellular processes.

GANC is a protein that has been identified as a potential drug target and has been shown to play a role in a number of diseases. Further research is needed to fully understand the role of GANC in cellular processes and to determine its potential as a drug target.

Protein Name: Glucosidase Alpha, Neutral C

Functions: Has alpha-glucosidase activity

The "GANC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GANC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets